Contract A207_PO-0447871-V3

Eurofins Genomics LLC has been awarded contract A207_PO-0447871-V3 by the University of Virginia, a contracting organization in Virginia, effective August 8, 2026. The contract totals $27 and covers the procurement of synthetic ribonucleic acid (RNA) oligonucleotides for research purposes. Specifically, the deliverables consist of six distinct RNA sequences: TogaRNAsc1 forward and reverse primers, TogaRNAsc5 forward and reverse primers, and FRMD4a forward and reverse primers, all synthesized as 25-nucleotide salt-free variants.

The contract line items specify quantities ranging from four to five units per sequence type, with each unit priced at $1. All materials are designated for delivery to the buyer. The procurement appears to support molecular research or diagnostic development activities at the University of Virginia, leveraging Eurofins Genomics LLC's capabilities in custom oligonucleotide synthesis and genetic research services. No information regarding performance period duration beyond the award date or specific place of performance is provided in the contract documentation.